ArticleEpigenetics & chromatin2026
Human Alu loci gain enhancer-type epigenetic modifications in monocytes during response to bacterial LPS.
Article in Epigenetics & chromatin, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
backgroundBacterial lipopolysaccharide (LPS) potently activates innate immunity. Transposable elements (TEs), particularly lineage-specific short interspersed elements (SINEs), have been implicated in immune regulatory evolution, yet their epigenomic roles during immune activation remain unclear.
resultsHere, we reanalyzed published ChIP-seq data for H3K4me1, H3K4me3, and H3K27ac from human monocytes and mouse macrophage-like cells under basal and LPS-stimulated conditions. We identified widespread and dynamic activation of Alu-associated regulatory regions in human monocytes, accounting for around 15% of total enhancer-associated ChIP-seq peaks with and without LPS stimulation. In particular, over one quarter of the Alu-containing H3K4me1 and H3K27ac peaks appeared only after LPS stimulation. The Alu-containing enhancers that appeared in short treatment with LPS linked to many genes involved in the acute immune and inflammatory responses. On the other hand, prolonged LPS stimulation produced stronger chromatin activation at Alu loci that were linked to genes with more dispersed pathway associations, likely reflecting post-stimulation adaptation or tolerance.
conclusionsThese findings suggest that Alu elements act as regulatory scaffolds that shape the temporal and functional landscape of human immune responses. Our findings suggest that Alu elements, as primate-specific TEs, may contribute to heightened sensitivity to LPS by shaping species-specific enhancer landscapes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.